Royalty Pharma
Buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
Launch date
Employees
Market cap
CAD16.9b
Enterprise valuation
CAD23.8b (Public information from Sep 2024)
Share price
$28.21 RPRX
New York City New York (HQ)
Authorizing premium user...